ALDH3A2 and gastric adenocarcinoma: In summary, a novel mitochondrial-related risk model was constructed using NOX4, FKBP10, ALDH3A2, and MAOA gene set, which could effectively predict the prognosis and immunotherapy responsiveness for patients with STAD.